UAE The UAE pharma market is projected to grow over 80 percent by 2027, in part due to a growing demand for the treatment of lifestyle diseases and expansion of comprehensive health insurance. Made with Visme Presentation Maker Pharmaceutical imports into the UAE come from 72 countries. 80 percent…
UAE LIFEPharma, a subsidiary of UAE-based VPS Healthcare, has signed a Dh 200 million (USD 55 million) deal with Canada’s Apotex to produce 120 million generic tablets and medicines for Motor Neurone Disease annually over the next 10 years. This partnership is an important milestone, not only for LIFEPharma and…
Thailand Suthep Namwongsamran, GM of M&H Manufacturing, provides insights into the distinctive model that has allowed M&H to become one of Thailand’s leading domestic pharmaceutical manufacturers. He also outlines the expected development of the M&H’s international strategy and his focus on bringing biosimilars to Thailand via mutually beneficial partnerships. We…
Sweden Sweden’s pharmaceutical exports shot up 27% in first quarter 2019, continuing an upward growth trend in an industry that is increasingly well-renowned internationally for its quality and high technology. The Swedish healthcare and life sciences sector enjoys a good reputation abroad and is strongly associated with quality and innovation…
Egypt Ashraf Osman, president and CEO of AUG Pharma, explains how his company has become one of Egypt’s Top 30 pharmaceutical companies in less than four years of manufacturing, gives an insight into the branding strategy of an industry newcomer, and outlines the company’s export strategy. In 2018 alone we…
Egypt Dr Maged George, chairman of the Egyptian Export Council of Medical Industries, highlights the obstacles that the Egyptian pharmaceutical industry is facing in the wake of the currency devaluation both locally and abroad. He also gives insights into Egypt’s new consolidated approach of targeting other African countries for exports, uniting…
Egypt Ahmed Zaghloul, CEO of October Pharma, stresses the need for better infrastructure for biosimilars in Egypt to stay competitive on a global level. He also highlights October Pharma’s ambitious export strategy, targeting markets in the Gulf Region and South East Asia. Production costs are rising, and pricing pressures continue,…
Turkey Imports and exports in Turkish pharma between 2010 and 2017. Pharmaceutical exports grew to a total of USD 898 million in 2017. These charts show both the volume and value of imported and locally-produced drugs in the Turkish pharma market between 2010 and 2017. TL 13.33 billion (USD 2.57…
Turkey Armağan Vurdu, general secretary of the Istanbul Minerals and Metals Exporters Association (IMMIB) highlights the strategic importance of the chemical and pharmaceutical sectors in Turkey’s exports. He underscores pharma’s role in Turkey’s ‘Vision 2023’ and explains how IMMIB is helping the sector increase its export potential. With our 29…
Turkey Seizing the cost competitiveness of the Turkish market and the government’s nurturing of local manufacturing, Turkish companies are looking to harness their geographic positioning and export to developed and developing markets alike. We did not shy away from entering the most advanced healthcare ecosystems. Barış Özyurtlu, General Manageger, Berko Ilac.…
Malta Malta has the second largest pharma trade balance per capita in the EU, the tenth in total, and was the continent’s fastest growing pharma exporter between 2001 and 2016. Malta acts a flight hub for southern Europe, with 35,000 international departures and arrivals per annum. Doing business in Malta is…
India Although most industry observers expect that Indian pharma exports to the US will pick up again in the coming years, Indian companies have – in the meantime – been rapidly increasing their efforts to develop stronger footprints in strategic emerging market such as Brazil, Russia and some Asian and African…
See our Cookie Privacy Policy Here